We demonstrated that knock-down of DLEU2 expression in CRC cells could suppress their proliferative and invasive capabilities by reducing the expression of CDK6, ZEB1, and ZEB2, as well as enhancing the expression of CDKN1A. Here, ZEB2 is linked to colorectal carcinoma.